XIENCE V Official Site

SPIRIT II & III Meta-Analysis 2-Year Results

ARC Stent Thrombosis figures are binominal. All other data from Kaplan Meier curves. TLF (Target Lesion Failure) = cardiac death, target vessel MI, or ID-TLR.

SPIRIT IV 1-year Data
Presented at TCT September 23, 2009, Gregg W. Stone, MD

Learn about the benefits of proven design

* XIENCE V has demonstrated statistical superiority in the primary endpoints of SPIRIT IV, SPIRIT III and SPIRIT II in target lesion failure, in-segment late loss and in-stent late loss respectively. Source: SPIRIT IV 1-year results, Gregg Stone, TCT 2009 and XIENCE V IFU. TAXUS Express was the control in SPIRIT IV.

References

Source: SPIRIT IV 1-year results, Gregg Stone, TCT 2009.

AP2931123 Rev. A

Site Map | International Terms of Use | International Privacy Policy | Contact Us

All illustrations are artist’s renditions.

Unless otherwise specified, all product names appearing in this Internet site are trademarks owned by or licensed to Abbott Laboratories, its subsidiaries or affiliates. No use of any Abbott trademark, trade name, or trade dress in this site may be made without the prior written authorization of Abbott Laboratories, except to identify the product or services of the company.